Gargett Caroline E, Chan Rachel W S, Schwab Kjiana E
Centre for Women's Health Research, Monash Institute of Medical Research, Monash University, Department of Obstetrics and Gynaecology, Monash Medical Centre, Clayton, Victoria Australia.
Mol Cell Endocrinol. 2008 Jun 25;288(1-2):22-9. doi: 10.1016/j.mce.2008.02.026. Epub 2008 Mar 4.
The human endometrium is a dynamic remodeling tissue undergoing more than 400 cycles of regeneration, differentiation and shedding during a woman's reproductive years. The co-ordinated and sequential actions of estrogen and progesterone direct these major remodeling events preparing a receptive endometrium for blastocyst implantation on a monthly basis. Adult stem/progenitor cells are likely responsible for endometrial regeneration. Functional approaches have been used to identify candidate endometrial stem/progenitor cells, as there are no specific stem cell markers. Rare populations of human endometrial epithelial and stromal colony-forming cells/units (CFU) and side population (SP) cells have been identified. Several growth factors are required for CFU activity: epidermal growth factor (EGF), transforming growth factor alpha (TGFalpha) and platelet-derived growth factor BB (PDGF-BB) for both epithelial and stromal CFU, and basic fibroblast growth factor (bFGF) for stromal, but not epithelial CFU. A sub-population of human endometrial stromal cells with mesenchymal stem cell properties of CFU activity and multilineage (fat, muscle, cartilage and bone) differentiation have been isolated by their co-expression of CD146 and PDGF-receptor beta. Candidate epithelial and stromal stem/progenitor cells have been identified in mouse endometrium as rare label retaining cells (LRCs) in the luminal epithelium and as perivascular cells at the endometrial-myometrial junction, respectively. While epithelial and most stromal LRC do not express estrogen receptor alpha (Esr1), they rapidly proliferate on estrogen stimulation, most likely mediated by neighbouring Esr1-expressing niche cells. It is likely that these newly identified endometrial stem/progenitor cells may play key roles in the development of gynecological diseases associated with abnormal endometrial proliferation such as endometriosis and endometrial cancer.
人类子宫内膜是一种动态重塑的组织,在女性的生殖年限中经历400多个再生、分化和脱落周期。雌激素和孕激素的协同及顺序作用主导着这些主要的重塑事件,每月为囊胚着床准备一个具有接受性的子宫内膜。成体干细胞/祖细胞可能负责子宫内膜的再生。由于没有特异性的干细胞标志物,因此已采用功能方法来鉴定候选子宫内膜干细胞/祖细胞。已鉴定出人类子宫内膜上皮和基质集落形成细胞/单位(CFU)及侧群(SP)细胞的稀有群体。CFU活性需要几种生长因子:上皮和基质CFU都需要表皮生长因子(EGF)、转化生长因子α(TGFα)和血小板衍生生长因子BB(PDGF-BB),基质CFU需要碱性成纤维细胞生长因子(bFGF),而上皮CFU则不需要。通过共表达CD146和血小板衍生生长因子受体β,已分离出具有CFU活性和多谱系(脂肪、肌肉、软骨和骨)分化的间充质干细胞特性的人类子宫内膜基质细胞亚群。在小鼠子宫内膜中,分别在腔上皮中鉴定出候选上皮干细胞/祖细胞为稀有标记保留细胞(LRC),在子宫内膜-肌层交界处鉴定为血管周围细胞。虽然上皮和大多数基质LRC不表达雌激素受体α(Esr1),但它们在雌激素刺激下迅速增殖,很可能由邻近表达Esr1的龛细胞介导。这些新鉴定的子宫内膜干细胞/祖细胞可能在与子宫内膜异常增殖相关的妇科疾病(如子宫内膜异位症和子宫内膜癌)的发展中起关键作用。